Latest On AVITA Therapeutics, Inc (AVMXF):
| Date/Time | Type | Description | Signal | Details |
|---|---|---|---|---|
| 2020-12-04 18:54 EST | Financials | Company financials have been released. | Neutral |  |
| 2020-11-27 00:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-11-07 19:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-10-08 20:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-26 16:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-17 08:54 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-03 07:18 EST | Financials | Company financials have been released. | Neutral | |
| 2020-09-01 07:27 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-31 08:19 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-14 12:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-06 15:59 EST | Financials | Company financials have been released. | Neutral | |
| 2020-08-04 19:15 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 11:40 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-31 04:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 20:12 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 08:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-30 00:23 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-28 16:36 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 23:21 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-27 15:57 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-23 20:46 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 12:10 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-09 07:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-07 07:03 EST | Stock Split | A stock split has occured on Jun 24, 2020 with a split factor of 5:100. | Neutral | |
| 2020-07-01 19:48 EST | Financials | Company financials have been released. | Neutral | |
| 2020-07-01 03:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-25 07:01 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-19 15:41 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-14 07:53 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-12 09:25 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-07 19:26 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-05 15:09 EST | Financials | Company financials have been released. | Neutral | |
| 2020-06-03 19:03 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-27 08:29 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-21 04:13 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-07 03:28 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-06 08:50 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-02 23:20 EST | Financials | Company financials have been released. | Neutral | |
| 2020-05-01 19:39 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-30 07:08 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-23 10:55 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-23 07:02 EST | Financials | Company financials have been released. | Neutral | |
| 2020-04-23 03:17 EST | Financials | Company financials have been released. | Neutral | |
About AVITA Therapeutics, Inc (AVMXF):
Carnegie Clean Energy Limited develops and commercializes the CETO wave energy technology for converting ocean wave energy into zero-emission electricity worldwide. It also produces and sells clean renewable energy using solar-battery systems to the Department of Defense. The company was formerly known as Carnegie Wave Energy Limited and changed its name to Carnegie Clean Energy Limited in December 2016. Carnegie Clean Energy Limited is based in North Fremantle, Australia.
General
- Name AVITA Therapeutics, Inc
- Symbol AVMXF
- Type Common Stock
- Exchange PINK
- Currency USD
- Country USA
- SectorHealthcare
- IndustryMedical Devices
- Last Split Factor5:100
- Last Split Date2020-06-24
- Fiscal Year EndJune
- Web URLhttp://www.carnegiece.com
View More
Valuation
- Price/Sales (Trailing 12 Mt.) 21.34
- Price/Book (Most Recent Quarter) 4.45
- Enterprise Value Revenue 31.17
- Enterprise Value EBITDA 1.77
View More
Financials
- Most Recent Quarter 2019-12-31
- Return on Assets -8%
- Return on Equity -27%
- Earnings Per Share -$0.01
- Revenue Per Share $0
- Gross Profit 357736
- Quarterly Earnings Growth -26.8%
View More
Highlights
- Market Capitalization 11.73 million
- Book Value Per Share $0.01
View More
Share Statistics
- Shares Outstanding 21.33 million
- Shares Float 7.19 billion
- % Held by Insiders 697%
- % Held by Institutions 38.6%
View More
Technicals
- Beta 0.62
- 52 Week High $5.15
- 52 Week Low $0.21
- 50 Day Moving Average 4.35
- 200 Day Moving Average 2.19
View More
Dividends
- Dividend Date N/A
- ExDividend Date N/A
View More
AVITA Therapeutics, Inc (AVMXF) Dividend Calendar:
| Ex-Dividend Date | Payment Date | Record Date | Declared Date | Amount |
|---|
AVITA Therapeutics, Inc (AVMXF) Company Financial Statements:
Financial statements are reports prepared by a company's management to present their financial performance and position at a point in time. A general-purpose set of financial statements usually includes a balance sheet, income statements, and statement of cash flows.
Income Statement:
| Date | Dec 31 2019 | Oct 31 2019 | Sep 30 2019 | Jul 31 2019 | Jun 30 2019 |
|---|---|---|---|---|---|
| Research Development | N/A | N/A | 3.52 million | N/A | 3.64 million |
| Income Before Tax | -318381.55 | N/A | -453439 | N/A | -453439 |
| Selling General Administrative | 313295.89 | N/A | 446196 | N/A | 446196 |
| Gross Profit | 25337.73 | N/A | 36086 | N/A | 2.38 million |
| Ebit | -294005.76 | N/A | -418723 | N/A | -10.05 million |
| Operating Income | -294005.76 | N/A | -418723 | N/A | -418723 |
| Income Tax Expense | N/A | N/A | N/A | N/A | -89932 |
| Total Revenue | 37263.73 | N/A | 53071 | N/A | 2.95 million |
| Cost of Revenue | 11925.99 | N/A | 16985 | N/A | 563754 |
| Total Other Income Expense Net | -24375.79 | N/A | -34716 | N/A | 165053 |
| Net Income From Continuing Operations | -318381.55 | N/A | -453439 | N/A | -453439 |
| Net Income Applicable to Common Shares | 327134 | 327134 | 327134 | 327134 | 327134 |
Cash Flow:
| Date | Jun 30 2020 | Mar 31 2020 | Dec 31 2019 | Oct 31 2019 | Sep 30 2019 |
|---|---|---|---|---|---|
| Investments | -263553.6 | -456000 | -190000 | N/A | N/A |
| Change to Liabilities | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Investing Activities | N/A | N/A | 420412 | 420412 | 420412 |
| Net Borrowings | N/A | N/A | N/A | N/A | N/A |
| Total Cash Flow from Financial Activities | 7.43 million | 597000 | 112.3 million | N/A | 2.65 million |
| Change to Operating Activities | N/A | N/A | N/A | N/A | N/A |
| Change in Cash | -15559.15 | -11.73 million | 105.78 million | N/A | 2.08 million |
| Total Cash from Operating Activities | N/A | N/A | -992118 | -992118 | -992118 |
| Depreciation | N/A | N/A | 3309.23 | N/A | 4713 |
| Other Cash Flow from Investing Activities | N/A | N/A | 532747 | 532747 | 532747 |
| Change to Inventory | N/A | N/A | N/A | N/A | N/A |
| Change to Account Receivables | N/A | N/A | N/A | N/A | N/A |
| Other Cash Flow from Financing Activities | N/A | N/A | -99490 | -99490 | -99490 |
| Change to Net Income | N/A | N/A | -1.32 million | -1.32 million | -1.32 million |
| Capital Expenditures | 263553.6 | 456000 | 190000 | N/A | 2143 |
Balance Sheet:
| Date | Jun 30 2020 | Dec 31 2019 | Oct 31 2019 | Sep 30 2019 | Jul 31 2019 |
|---|---|---|---|---|---|
| Total Liabailities | 10.06 million | 12.21 million | N/A | 3.5 million | N/A |
| Total Stockholder Equity | 72.4 million | 123.87 million | N/A | 18.74 million | N/A |
| Other Current Liabilities | 560000 | 45051.96 | N/A | 64163 | N/A |
| Total Assets | 82.46 million | 136.08 million | N/A | 22.24 million | N/A |
| Common Stock | N/A | 203.13 million | N/A | 203.13 million | N/A |
| Other Current Assets | N/A | N/A | 203.13 million | N/A | 203.13 million |
| Retained Earnings | -194.91 million | -205.06 million | -185.32 million | -185.32 million | -185.32 million |
| Other Liabilities | N/A | 63538 | 63538 | 63538 | 63538 |
| Other Assets | N/A | 708159 | 708159 | 708159 | 708159 |
| Cash | 73.64 million | 124.66 million | N/A | 4.41 million | N/A |
| Total Current Liabilities | 7.71 million | 8.48 million | N/A | 530875 | N/A |
| Other Stockholder Equity | N/A | 925874 | 925874 | 925874 | 925874 |
| Property, Plant & Equipment | N/A | 2.79 million | 2.79 million | 2.79 million | 2.79 million |
| Total Current Assets | 78.39 million | 130.24 million | N/A | 4.45 million | N/A |
| Long Term Investments | N/A | 8716.47 | N/A | 12414 | N/A |
| Net Tangible Assets | N/A | 4.46 million | 4.46 million | 4.46 million | 4.46 million |
| Short Term Investments | N/A | N/A | N/A | N/A | N/A |
| Long Term Debt | N/A | 1.98 million | N/A | 2.83 million | N/A |
| Inventory | 1.13 million | 1.27 million | N/A | 1.27 million | N/A |
| Accounts Payable | 4.33 million | 3.72 million | N/A | 86706 | N/A |
AVITA Therapeutics, Inc (AVMXF) Chart:
AVITA Therapeutics, Inc (AVMXF) News:
Below you will find a list of latest news for AVITA Therapeutics, Inc (AVMXF) from major news sources. You can filter the results to only show news from a specific source.
No recent news available
AVITA Therapeutics, Inc (AVMXF) Options:
A stock option is a contract between two parties in which the stock option buyer (holder) purchases the right (but not the obligation) to buy/sell 100 shares of an underlying stock at a predetermined price from/to the option seller (writer) within a fixed period of time.
| Expiration Date | Strike | Last Price | Type | Volume | Open Interest | Implied Volatility | In The Money | Change | Change Percent |
|---|
AVITA Therapeutics, Inc (AVMXF) SEC Filings:
An SEC filing is a financial statement or other formal document submitted to the U.S. Securities and Exchange Commission (SEC). Public companies, certain insiders, and broker-dealers are required to make regular SEC filings.
| Date | Form Type | Form Name | Link |
|---|